Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Computer-Aided Identification of Recognized Drugs as Pseudomonas aeruginosa Quorum-Sensing Inhibitors

Liang Yang, Morten Theil Rybtke, Tim Holm Jakobsen, Morten Hentzer, Thomas Bjarnsholt, Michael Givskov, Tim Tolker-Nielsen
Liang Yang
Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morten Theil Rybtke
Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Holm Jakobsen
Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morten Hentzer
Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Bjarnsholt
Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Givskov
Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Tolker-Nielsen
Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ttn@sund.ku.dk
DOI: 10.1128/AAC.01283-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    2D structures of the compounds tested in this study. (A) Structures of the known LasR binding compounds used in the 2D similarity search against the SuperNatural and SuperDrug databases (OdDHL, TP-1, furanone C30, and patulin) and included in the SB-VS for reference (OdDHL) and comparison (all). (B) Structures of the six compounds tested for the ability to inhibit LasR in P. aeruginosa.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Dose-response curves of the three drugs salicylic acid (A), nifuroxazide (B), and chlorzoxazone (C) when incubated together with PAO1 lasB::gfp(ASV). The three compounds reduce the RFU level (GFP fluorescence units divided by OD450) at various concentrations (right), indicating inhibition of LasR, while displaying no effect on growth (left). Growth is displayed as the increase in OD450 compared to the initial level. Salicylic acid and nifuroxazide were tested at concentrations of 400 (▪), 200 (Δ), 50 (•), 12.5 (□), 3.125 (▴), and 0 (○) μg/ml, while chlorzoxazone was tested at 200 (▪), 100 (▵), 20 (•), 6.25 (□), 1.5625 (▴), and 0 (○) μg/ml. Results are representative of three independent experiments.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Expression of rhlA::gfp(ASV) (A) and pqsA::gfp(ASV) (B) in wild-type and lasR mutant P. aeruginosa PAO1 treated with the three identified LasR inhibitors. Results are average RFU values taken from a single time point measurement corresponding to maximal induction of the reporters in the late log phase of growth. Inhibitors were added at concentrations of 200 μg/ml for salicylic acid and nifuroxazide and 100 μg/ml for chlorzoxazone. Averages and SDs of eight replicates are shown.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Inhibition of exogenous protease production (A), pyoverdine production (B), and rhamnolipid production (C) in P. aeruginosa treated with the three identified LasR inhibitors. 1, untreated; 2, lasI rhlI mutant (QS deficient); 3, salicylic acid treated; 4, nifuroxazide treated; 5, chlorzoxazone treated. Results were taken after 18 h of growth at 37°C. Averages and SDs of five replicates are shown. Relat., relative; activ., activity; prod., production.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    CLSM pictures of 4-day-old P. aeruginosa biofilms. A, untreated; B, lasI rhlI mutant (QS deficient); C, salicylic acid treated; D, nifuroxazide treated; E, chlorzoxazone treated. The strains were GFP tagged for visualization. The main pictures are top-down 3D projections, while the flanking pictures are vertical sections. Bars, 20 μm.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Results of COMSTAT analysis for total biomass calculation of the individual biofilms. 1, untreated; 2, lasI rhlI mutant (QS deficient); 3, salicylic acid treated; 4, nifuroxazide treated; 5, chlorzoxazone treated. Averages and SDs from analysis of 12 images taken at random positions in three different biofilms are shown.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Scenes displaying the conformations (magenta) of the identified LasR inhibitors and known LasR inhibitors as proposed by MVD after docking of the compounds. A, salicylic acid; B, nifuroxazide; C, chlorzoxazone; D, 4-NPO, the known LasR inhibitor used as cutoff in the docking; E, furanone C30, a potent LasR and QSI; F, OdDHL, the natural LasR ligand, as it is present in the LasR crystal structure with its hydrogen bonds (black lines) to the protein (green residues). In scenes A to E, hydrogen bonds proposed by MVD to occur upon binding are shown as black dotted lines together with the interaction residues (green). The conformation of OdDHL (white) has been included in scenes A to E for comparison, and the backbone of the LasR ligand binding domain is shown in blue-white with α-helical residues 65 to 72 omitted for clarity.

Tables

  • Figures
  • Additional Files
  • TABLE 1.

    Names and types of LasR binding compounds used as references and for comparison in the SB-VS

    CompoundTypeReference
    3-Oxo-C12-HSLNatural ligand45
    3-Oxo-C12-(2-aminophenol)Inhibitor62
    4-Nitropyridine-N-oxideInhibitor50
    Furanone C30Inhibitor29
    PatulinInhibitor51
    Penicillic acidInhibitor51
    TP-1Activator42
    TP-5Inhibitor42
  • TABLE 2.

    Rerank scores, similarity scores, and molecular weights of the acquired compounds, the reference ligand, and the known LasR binding compounds included for comparisona

    CompoundMol wtSimilarity scoreRerank score
    Acquired compounds
        Indoramine340.4−491.29−121.281
        Nifuroxazide274.2−447.124−86.3983
        Tiaprofenic acid258.3−396.031−71.4197
        Donepezil370.4−499.284−70.7016
        Chlorzoxazone169.6−344.493−69.6008
        Salicylic acid138.1−336.595−66.156
    Reference, 3-oxo-C12-HSL297.4−129.739
    Known LasR binders
        3-Oxo-C12-(2-aminophenol)305.4−470.817−93.8255
        Patulin154.1−354.068−70.1662
        4-NPO140.1−305.698−63.1366
        Furanone C30257.9−265.816−47.9107
        Penicillic acid170.2−315.51675.4073
        TP-1568.6−497.462220.864
        TP-5385.2−398.532431.434
    • ↵a The compounds were ranked on the basis of their rerank scores. The scores of the individual compounds are the best of five scores derived from independent docking rounds.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 - Supplemental table showing settings used in Molegro Virtual Docker for import of molecules, template creation, and docking of the compound database. Legends for supplemental figures.
      Zipped Word document, 8K.
    • Supplemental file 2 - Figure showing template assignment to the individual heavy atoms of the natural ligand 3-oxo-C12-HSL present in the LasR ligand binding domain used for the docking.
      Zipped TIFF image, 374K.
    • Supplemental file 3 - Figure showing a representative result of the drop-collapse biosurfactant assay used to qualitatively estimate the production of rhamnolipid.
      Zipped TIFF image, 1.5MB.
PreviousNext
Back to top
Download PDF
Citation Tools
Computer-Aided Identification of Recognized Drugs as Pseudomonas aeruginosa Quorum-Sensing Inhibitors
Liang Yang, Morten Theil Rybtke, Tim Holm Jakobsen, Morten Hentzer, Thomas Bjarnsholt, Michael Givskov, Tim Tolker-Nielsen
Antimicrobial Agents and Chemotherapy May 2009, 53 (6) 2432-2443; DOI: 10.1128/AAC.01283-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Computer-Aided Identification of Recognized Drugs as Pseudomonas aeruginosa Quorum-Sensing Inhibitors
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
Share
Computer-Aided Identification of Recognized Drugs as Pseudomonas aeruginosa Quorum-Sensing Inhibitors
Liang Yang, Morten Theil Rybtke, Tim Holm Jakobsen, Morten Hentzer, Thomas Bjarnsholt, Michael Givskov, Tim Tolker-Nielsen
Antimicrobial Agents and Chemotherapy May 2009, 53 (6) 2432-2443; DOI: 10.1128/AAC.01283-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596